Monsanto: Update for Analyst Ratings and Price Target
In 2017, Monsanto (MON) peaked at $122.30 but ended the year at $118.80, delivering a return of 12.8% from stock appreciation alone. The company is pending a merger with Bayer, but it is facing regulatory hurdles. Eighteen Wall Street analysts are covering Monsanto.